INTERNATIONAL CONFERENCE ON ADVANCED TREATMENT OF COLON CANCER Improving treatment of colon cancer. What is essential? JUNE 9.- 10. 2011 BERGEN, NORWAY.

Slides:

Advertisements

Similar presentations

What is the most appropriate therapy for a 50 year old patient with T3N+ rectal cancer and isolated surgically resectable liver Metastases? – Systemic.

Advertisements

MDT I AARHUS Søren Laurberg Professor of Surgery Aarhus University Hospital Denmark.

Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.

Cornelis J.H. van de Velde, MD, PhD,FRCPS(hon)FACS(hon) Professor of Surgery President ECCO - the European Cancer Organization Past-President European.

Polyps – Where do they come from and what do you do with them?!

Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.

Colorectal Cancer Surgery

A COMPARISON of LAPAROSCOPICALLY ASSISTED and OPEN COLECTOMY for COLON CANCER The Clinical Outcomes of Surgical Therapy Study Group (Cost Study) NEJM,

Assessment of Margins in Colorectal Cancer Specimens Holly Brunner, PA(ASCP) Sibley Memorial Hospital Washington, DC.

JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.

Trials in gastric cancer surgery Presenter Dr Pankaj Kumar Garg Moderator Dr Sunil Kumar.

Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.

Colon Cancer Basic Science 9/21/05. Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths.

How to get more nodes in laparoscopic colon surgery John Marks MD Chief Division of Colorectal Surgery Lankenau Hospital and Institute of Medical Research.

62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

Managing the patients experience of radical surgery with HIPEC for stage 4 colorectal disease Jackie Rodger Lead Colorectal Nurse Specialist Carol Baird.

Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.

Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.

Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.

Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.

University of Glasgow, Clinical Anatomy Skills Centre, Department of Anatomy, Glasgow 14 th – 15 th November 2014 Advanced Laparoscopic Surgery Course.

© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.

Colon Cancer First Page.

Northern Region Colorectal Cancer Audit (NORCCAG) Colorectal NSSG – Audit meeting 1 st April 2006 – 31 st July 2010 Dorothy Simms – Audit Co-ordinator.

Metastasis Steps to metastases:

Resection For Lung Metastases M62 Coloproctology Course.

Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.

Specialist surgery “Some surgeons perform less than optimal surgery. Some are less competent technically than their colleagues; and some fail to supervise.

Treatment strategies for colon cancer at TNM stage IV Gunnar Arbman Department of Surgery Norrköping, Sweden Bergen June 2011.

Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara.

Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment.

1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,

The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena

Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.

Eric Van Cutsem Head, Digestive Oncology, University Hospital Gasthuisberg and Professor of Internal Medicine, University of Leuven, Belgium Published.

Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.

Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.

Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.

Prognosis of colon cancer compared with rectal cancer. Where lies the difference? Bjørn S. Nedrebø Stavanger University Hospital.

Enhanced biomedical scientist cut-up role in colonic carcinoma; preliminary performance data and comparison with departmental performance. E. J. V. Simmons*

Local recurrence after rectal cancer resection is strongly related to the plane of surgical (PoS) dissection and is further reduced by pre-operative short.

Management of Recurrent and Advanced Tumours: When are Tumours Resectable, and Multidisciplinary Management Dr. Andrew McFadden Surgical Oncology.

Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.

Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.

Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.

Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma JIN Chen, YAO Lie, LONG.

Surgery of colorectal metastasis in the Optimox 1 study. A GERCOR Study. N. Perez-Staub, G. Lledo, F. Paye, B. Gayet, M. Flesch, A. Cervantes, A. Figer,

The Cancer Registry of Norway Jan F Nygård Head of the IT-department.

CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.

Gallbladder Cancer Surgical Management

Staging laparoscopy US study: patients with gastric cancer In hospital mortality Staging laparoscopy alone: 5.3% Futile laparotomy: 13.1%

Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.

Laparoscopic surgery for rectal cancer What is the evidence?

Karcinom rektuma- management

Joint Hospital Surgical Grand Round Dr Stewart Chan Kwong Wah Hospital

CST Training Day – Tuesday 7th March 2017 Lister Education Centre Lister Hospital, Coreys Mill Lane, Stevenage SG1 4AB Timetable: Registration.

Department of General Surgery, Upper Gastrointestinal Unit,

Neo-adjuvant treatment for metastatic colon cancer in geriatric patients followed by simultaneous hepatic resection: A case report Sotiropoulos GC, Machairas.

The presence of lung metastases does not influence survival in liver metastatic colorectal cancer Jennie Engstrand1, Henrik Nilsson1, Cecilia Strömberg2,

A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.

Proposed Changes to the 7th Edition

تهیه کننده: استاد مربوطه: بهار 1392

Dr Jessica Jenkins Consultant Oncologist

PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

The STAR-TREC Trial SIV Presentation

The 10-year cumulative incidence of CRC death or death due to other causes in patients treated with adjuvant chemotherapy after surgery for stages II–III.

Assessment of Breast and Colorectal Cancer Surgery in Manitoba

Presentation transcript:

INTERNATIONAL CONFERENCE ON ADVANCED TREATMENT OF COLON CANCER Improving treatment of colon cancer. What is essential? JUNE BERGEN, NORWAY Can the success of TME for rectal cancer be emulated by CME (complete mesocolic excision)? The University of Bergen, Dept. of Surgical Sciences, and Haraldsplass Deaconal Hospital, Department of Surgery, invite you to learn about the concept of radical colon cancer surgery and treatment from world class speakers. Organising committee: Professor dr. med. Karl Søndenaa Dr. med. Kari Erichsen The full course is registered for 16 hours. Fee: NOK 3200 (300 €) Practical information, registration form and hotel accommodation is available online at: Pre- and post-congressional tours will also be available. We are delighted to invite you to the beautiful World Heritage City of Bergen and look forward to seeing you in Bergen in June. Venue: VilVite – Bergen Science Centre Thormøhlensgate Bergen

PROGRAM - BERGEN JUNE , 2011 Improving treatment of colon cancer. What is essential? THURSDAY, JUNE 9 Moderators Torbjörn Holm and Karl Søndenaa 08.15Introduction. Karl Søndenaa 08.30Resectional approach for colon and rectosigmoid cancer based on anatomy and lymphatic spread. Werner Hohenberger 09.00The Japanese approach to colon cancer resections based on the vascular anatomy of the colon and rectosigmoid. Kenichi Sugihara 09.30Turnbull’s good results in view of today’s concept of mesocolon and the central tie. Defining the surgical approach. Feza Remzi 10.00Coffee break 10.30Differences between open and laparoscopic surgery? Kristian Storli 11.00When is the laparoscopic approach permissible? Kenichi Sugihara 11.30Discussion Lunch Moderators Arild Nesbakken and Werner Hohenberger 13.00Overview of the radical colon cancer surgery project in Bergen. Karl Søndenaa 13.30Background data from the Stockholm region colon project. Torbjørn Holm 13.45Recent experience with the Stockholm region colon project. Richard Bernhoff Discussion 14.30Coffee break Adequate treatment of rectosigmoid cancer. Heinz Becker Size of specimen with CME evaluation, lymph node numbers, LNR and other specific issues for the pathologist to decide. Nick West 16.00Are micrometastases crucial to staging and survival? Arne Færden 16.20–17.00 Discussion FRIDAY, June 10 Moderators Werner Hohenberger and Feza Remzi 08.30Should pulmonary CRC metastases be resected? Tom Treasure The treatment of hepatic, pulmonary and cerebral CRC metastases in Western Norway. Lessons for the colorectal surgeon. Arild Horn, Bjarte Hjelmeland and P-H Pedersen The need for adjuvant chemotherapy. Is it evidence based and when? Halfdan Sørbye Discussion Coffee break Treatment strategies for colon cancer at TNM stage IV. Gunnar Arbman HIPEC treatment of intra-abdominal recurrence. Stein G. Larsen Discussion 12.00–13.00 Lunch Moderators Torbjörn Holm and Karl Søndena Lessons learned past and present in Oslo. Ole Sjo Treatment of colon cancer in Northern Norway. Long distances - any significance for the patient and who should treat him? Rolv-Ole Lindsetmo Prognosis of colon cancer compared with rectal cancer. Where lies the difference. Bjørn Nedrebø Recent trends in colorectal cancer in Norway: incidence, management, and outcome. Arne Wibe Coffee break Morbidity and mortality after introduction of radical colon cancer surgery. Bjørg Furnes Panel debate: 14.45Why do some achieve better results? Is the surgeon, hospital or dedication crucial? Werner Hohenberger 15.00What can the Japanese experience teach others? Professor Kenichi Sugihara 15.15Current teaching in the US. Feza Remzi 15.30–16.00 Closing remarks and discussion